Jon Faiz Kayyem bought $500K of INBX stock

Jon Faiz Kayyem, Dir of Inhibrx Biosciences, Inc. (INBX), bought 5,000 shares of INBX stock worth $500K, per an SEC Form 4 filed Sep 23, 2026.

It was an open-market purchase.

The trade was reported on Sep 23, 2026.

INBX has moved -15.8% since the trade date, from $100.33 to $84.52 (Nov 6, 2026 close).